Part of the seamy side of vaginal mesh litigation was reported in an April 14, 2018 article in the NYT. The article, “How Profiteers Lure Women Into Often-Unneeded Surgery,” describes some of the financing companies that operate alongside the mass tort claims involving vaginal mesh. There are some very real problems with vaginal mesh in some settings, but this article highlights instance where the financiers and doctors worsened a situation for profit.

The article is yet another example of why all courts hearing mass tort cases should force transparency on all sides, including insurers. Protective orders and secrecy may be convenient, but sunshine remains the best disinfectant, in my opinion.